Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors

von I. O. Zhaleiko, T. P. Perekhrestenko, D. I. Bilko, I. S. Dyagil, N. M. Bilko
Veröffentlicht 2014

TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia

von N. I. Bilous, I. V. Abramenko, A. A. Chumak, I. S. Dyagil, Z. V. Martina
Veröffentlicht 2014

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy

von I. O. Sviezhentseva, T. P. Perekhrestenko, D. I. Bilko, A. I. Gordienko, M. V. Diachenko, I. S. Dyagil
Veröffentlicht 2015